vimarsana.com

Page 43 - ஐரோப்பிய தொழிற்சங்கம் அறிவுசார் ப்ராபர்டீ அலுவலகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Facing Supply Chain Concerns In The COVID-19 Era - Intellectual Property

To print this article, all you need is to be registered or login on Mondaq.com. In late October, British financial research firm Moody s issued a report indicating that supply chain issues caused by the COVID-19 pandemic would result in rising consumer costs in hospital care. With many countries shifting to domestic manufacturing to counter the spread of coronavirus through international channels, medical supplies like personal protective equipment (PPE) and pharmaceuticals are expected to be more expensive to produce. Supply chain constraints during COVID-19 times are also likely to impact public construction projects and restrict new hospital builds, further affecting a sector that is already heavily burdened by the

European Union Intellectual Property Office Revokes Counterfeiter s Fake AQUAGOLD® Design Registrati

Search jobs 10-Dec-2020 European Union Intellectual Property Office Revokes Counterfeiter s Fake AQUAGOLD® Design Registration and Orders Payment to Aquavit of All Legal Fees and Costs NEW YORK, Dec. 10, 2020 /PRNewswire/ Aquavit Pharmaceuticals, Inc. ( Aquavit ) received a decision from the European Union Intellectual Property Office (EUIPO) today that it has revoked the counterfeiter U-BioMed s falsely registered AQUAGOLD® design, originally created and owned by Aquavit. AQUAGOLD® fine touch™ is Aquavit s world-renowned microchannel microinjector medical device. Aquavit introduced AQUAGOLD® fine touch™ at the American Academy of Dermatology (AAD) in 2014 and has been praised globally by doctors, patients, key opinion leaders, and the media. AAD is the largest dermatology conference in the world, attended by tens of thousands of doctors and healthcare professionals from around the world.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.